Companies: 10,795·Total market cap: $144.5T
Lifeward Ltd.

Lifeward Ltd.

LFWDNASDAQHealthcare● Active
$6.98
$-0.03(-0.36%)
Market Cap$11244787
P/E Ratio
52W High$15
52W Low$4.14

Lifeward Ltd. (LFWD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lfwd · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Lifeward Ltd. (LFWD) measures how much investors pay for each dollar of the company's trailing earnings. LFWD's current PE ratio of N/A is calculated by dividing its stock price of $6.98 by its TTM earnings per share of -$16.06.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-1.75
Based on 1 analyst
EPS (TTM)
-$16.06
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lifeward Ltd. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Lifeward Ltd.
Lifeward Ltd.You
LFWD
$11MN/A-$16.06
DIH Holding US, Inc.
DIH Holding US, Inc.
DHAI
$0MN/A-$6.07
Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd.
IINN
$45MN/A-$0.45
IN8bio, Inc.
IN8bio, Inc.
INAB
$7MN/A-$4.44
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc.
LYRA
$1MN/A-$1.86
Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd Class A Ordinary Shares
PTHL
$4MN/A-$0.05
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc.
RNAZ
$5MN/A-$50.25

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.72
2024-12-31
FY2024
$-39.98
2023-12-31
FY2023
$-31.14
2022-12-31
FY2022
$-26.36
2021-12-31
FY2021
$-22.33
2020-12-31
FY2020
$-69.17
2019-12-31
FY2019
$-226.75
2018-12-31
FY2018
$-1236.96
2017-12-31
FY2017
$-2568.74
2016-12-31
FY2016
$-5181.63

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Lifeward Ltd. (LFWD) measures how much investors pay for each dollar of the company's trailing earnings. LFWD's current PE ratio of N/A is calculated by dividing its stock price of $6.98 by its TTM earnings per share of -$16.06.

PE Ratio = Stock Price ÷ EPS (TTM)
= $6.98 ÷ -$16.06 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LFWD pe ratio · 6 questions

LFWD's current PE ratio is N/A as of 2026-06-09, based on a stock price of $6.98 and TTM EPS of -$16.06. Data sourced from Financial Modeling Prep via LFWD's SEC 10-K and 10-Q filings.

LFWD PE ratioWhat is LFWD PE ratioCurrent PE ratio of LFWDLFWD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lifeward Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09